Arsanis

Developer of monoclonal antibodies to treat infectious diseases

placeWaltham, Massachusetts, United States calendar_todayFounded 2010 groups73 employees language arsanis.com

Registered entities

Investor mix

11 investors on record; lead investors include Gates, Orbimed, Polaris Partners, NeoMed; 1 has since exited.

Investor typeCountShare
Venture capital764%
Accelerator & incubator19%
Other / undisclosed327%
Coming soon